![]() Guided Therapeutics Guided Therapeutics is a medical technology company developing biophotonics solutions for the non-invasive detection of cancer. | Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | P-cure P-cure is a company that provides a gantry-less proton therapy system that fits any radiation oncology department. | Microvascular Therapeutics Microvascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100. | GratXray GratXray is a medical device company that develops and markets systems based on phase contrast-enhanced X-ray imaging. | |
Founding Date | Founding Date 1992 | Founding Date 2013 | Founding Date 2007 | Founding Date 2016 | Founding Date 2017 |
Type | Type Public | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Peachtree Corners, US HQ | Locations København, DK HQ | Locations Shilat HQ Akron, US | Locations Tucson, US HQ | Locations Villigen, CH HQ |
Employees | Employees 10 | Employees 7 | Employees 442% increase | Employees 1220% increase | Employees 5 |
Funding | |||||
Total funding raised | Total funding raised $ 8.6m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 1.6m | Total funding raised N/A |
Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR).
View companyP-cure is a company that provides a gantry-less proton therapy system that fits any radiation oncology department.
View companyMicrovascular Therapeutics (MVT) is a biotechnology company engaged in the development of an ultrasound contrast agent, MVT-100.
View companyGratXray is a medical device company that develops and markets systems based on phase contrast-enhanced X-ray imaging.
View company